A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone-induced interstitial pneumonia

L Cappannoli, A Telesca, R Scacciavillani… - Future …, 2021 - Taylor & Francis
Amiodarone is a drug commonly used to treat and prevent cardiac arrhythmias, but it is often
associated with several adverse effects, the most serious of which is pulmonary toxicity. A 79 …

[HTML][HTML] Amiodarone-induced organizing pneumonia mimicking COVID-19: a case report

G Zizzo, S Caruso, E Ricchiuti, R Turato… - European Journal of …, 2021 - Springer
Background Differential diagnosis of interstitial lung diseases (ILDs) during the COVID-19
pandemic is difficult, due to similarities in clinical and radiological presentation between …

[HTML][HTML] Case report of amiodarone-associated allergic pneumonitis amidst the COVID-19 pandemic

M Azraai, M McMahon, R Dick - Reviews in Cardiovascular Medicine, 2021 - imrpress.com
Amiodarone is a common antiarrhythmic drug that is utilised in clinical practice and is
associated with pulmonary toxicity. The most common form of pulmonary complication is …

[HTML][HTML] Amiodarone for the treatment of arrhythmias in COVID-19 patients does not increase the risk of pulmonary fibrosis: a retrospective cohort study

DB Money, DH Lee, A Hadar, J Doherty, C Malanga… - Cureus, 2023 - ncbi.nlm.nih.gov
Amiodarone is a class III antiarrhythmic medication used to treat atrial and ventricular
tachyarrhythmias. Pulmonary fibrosis from amiodarone use is a well-documented side effect …

Safety and efficacy of amiodarone in a patient with COVID-19

N Castaldo, A Aimo, V Castiglione, C Padalino… - Case Reports, 2020 - jacc.org
There is an urgent need for effective treatments for coronavirus disease-2019 (COVID-19).
Amiodarone, like hydroxychloroquine, exerts antiviral actions by interfering with endocytosis …

[HTML][HTML] Amiodarone in the COVID-19 era: treatment for symptomatic patients only, or drug to prevent infection?

F Sanchis-Gomar, CJ Lavie, DP Morin… - American Journal of …, 2020 - Springer
Amiodarone, one of the most widely prescribed antiarrhythmic drugs to treat both ventricular
and supraventricular arrhythmias, has been identified as a candidate drug for use against …

[HTML][HTML] A case report and literature review: previously excluded tuberculosis masked by amiodarone induced lung injury

E Karinauske, S Abramavicius, G Musteikiene… - BMC Pharmacology and …, 2018 - Springer
Background Amiodarone is an antiarrhythmic drug which is used to treat and prevent
several dysrhythmias. This includes ventricular tachycardia and fibrillation, wide complex …

Amiodarone-induced pneumonitis

H Matsuura, Y Kiura, W Shimizu… - … Journal of Medicine, 2021 - academic.oup.com
A 70-year-old woman with acute history of fever, cough and myalgia, presented to our
emergency department. Her previous significant medical history was mild hypertension and …

[HTML][HTML] Acute respiratory distress syndrome complicated by amiodarone induced pulmonary fibrosis: don't let your guard down

VK Singh, V Maheshwari - Journal of clinical and diagnostic …, 2017 - ncbi.nlm.nih.gov
Amiodarone is an antiarrhythmic agent which is commonly used to treat both
supraventricular and ventricular arrhythmias. This iodine containing compound has been …

[HTML][HTML] Organizing pneumonia secondary to amiodarone treatment

JG Carvalho, C Fernandes, M França - Heliyon, 2022 - cell.com
Amiodarone is a widely prescribed antiarrhythmic drug with a relatively high incidence of
adverse effects associated with its long-term oral use. Pulmonary toxicity may manifest as …